Schedule 13G ownership disclosure

Avalo Therapeutics, Inc.

Common Stock, $0.001 Par Value · CUSIP: 05338F306

Event date: 2025-08-06

Filing-level shares
549,467.00
Percent of class
4.2%
  • Patrick J. Crutcher

    Shares: 549,467.00 · Class: 4.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-025721
Form type
SCHEDULE 13G/A
Filer
Avalo Therapeutics, Inc.
CIK
CIK 1534120
Filed
Aug 27, 2025
Reporting period
Aug 06, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub